Biotech Investment Veteran Alethia Young Joins PTC Therapeutics’ Board of Directors

SOUTH PLAINFIELD, N.J., June 9, 2022 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the election of Alethia Young to the company’s Board of Directors. Ms. Young has more than 20 years of experience in healthcare and biotech equity research and investing. She is…

About the Author

has written 42205 stories on this site.

Copyright © 2010 Business and Corporate News.